16 min listen
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
ratings:
Length:
90 minutes
Released:
Dec 8, 2023
Format:
Podcast episode
Description
Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer, moderated by Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Lung).
CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Lung).
Released:
Dec 8, 2023
Format:
Podcast episode
Titles in the series (100)
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson: Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic. by Oncology Today with Dr Neil Love